Nancy Simonian
Overview
Nancy Simonian received an average of $3M in total compensation, including $561K in salary, at Syros Pharmaceuticals from 2015 to 2023.
2023Syros PharmaceuticalsFormer President & Chief Executive Officer
2022Syros PharmaceuticalsPresident & Chief Executive Officer
2021Syros PharmaceuticalsPresident & Chief Executive Officer
2020Syros PharmaceuticalsPresident & Chief Executive Officer
2019Syros PharmaceuticalsPresident & Chief Executive Officer
2018Syros PharmaceuticalsPresident & Chief Executive Officer
2017Syros PharmaceuticalsPresident & Chief Executive Officer
2016Syros PharmaceuticalsPresident & Chief Executive Officer
2015Syros PharmaceuticalsPresident & Chief Executive Officer
Source: SEC filings on April 23, 2024, April 21, 2023, April 21, 2022, April 29, 2021, April 28, 2020, April 25, 2019, April 26, 2018, and April 25, 2017.
Related executives
We found seven more executives who work or worked at Syros Pharmaceuticals.
Eric Olson
Syros Pharmaceuticals
Chief Scientific Officer
David Roth
Syros Pharmaceuticals
Chief Medical Officer
Jason Haas
Syros Pharmaceuticals
Chief Financial Officer
Joseph Ferra
Syros Pharmaceuticals
Chief Financial Officer
Jeremy Springhorn
Syros Pharmaceuticals
Chief Business Officer
Gerald Quirk
Syros Pharmaceuticals
Chief Legal Officer
Kyle Kuvalanka
Syros Pharmaceuticals
Chief Operating Officer
News
Syros Pharmaceuticals CEO Nancy Simonian's 2023 pay falls 59% to $1.4M
April 23, 2024
Syros Pharmaceuticals CEO Nancy Simonian's 2022 pay rises 12% to $3.5M
April 21, 2023
Syros Pharmaceuticals CEO Nancy Simonian's 2021 pay jumps 23% to $3.1M
April 21, 2022
Syros Pharmaceuticals CEO Nancy Simonian's 2020 pay falls 30% to $2.5M
April 29, 2021
Syros Pharmaceuticals CEO Nancy Simonian's 2019 pay rises 19% to $3.6M
April 28, 2020
Syros Pharmaceuticals CEO Nancy Simonian's 2018 pay jumps 36% to $3M
April 25, 2019